A novel cytomegalovirus-induced regulatory-type T-cell subset increases in size during older life and links virus-specific immunity to vascular pathology.
about
Cell-mediated immunity to human CMV infection: a brief overviewEpstein-Barr virus and cytomegalovirus infections and their clinical relevance in Egyptian leukemic pediatric patients.Cytomegalovirus infection in HIV-infected and uninfected individuals is characterized by circulating regulatory T cells of unconstrained antigenic specificity.Anti-CMV-IgG positivity of donors is beneficial for alloHSCT recipients with respect to the better short-term immunological recovery and high level of CD4+CD25high lymphocytes.Elevated HbA(1c) levels and the accumulation of differentiated T cells in CMV(+) individualsGender differences and age-specific associations between body mass index and other cardiovascular risk factors in CMV infected and uninfected people.Functional Diversity of Cytomegalovirus-Specific T Cells Is Maintained in Older People and Significantly Associated With Protein Specificity and Response Size.Latent Cytomegalovirus (CMV) Infection Does Not Detrimentally Alter T Cell Responses in the Healthy Old, But Increased Latent CMV Carriage Is Related to Expanded CMV-Specific T Cells.IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection.CMV-Specific T-cell Responses at Older Ages: Broad Responses With a Large Central Memory Component May Be Key to Long-term Survival.Restimulating interest in cytomegalovirus as a cofactor for HIV infection.New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection.A constant companion: immune recognition and response to cytomegalovirus with aging and implications for immune fitness.CMV immune evasion and manipulation of the immune system with aging.Age-related differences in humoral and cellular immune responses after primary immunisation: indications for stratified vaccination schedules.
P2860
Q27026981-69CAE7F9-B99B-4E9D-9384-91C6696813FDQ33439883-7B1DCCB4-B49A-4C34-90EF-E72613AB4914Q33880763-DA6B8F46-0DD5-4CCA-BC09-71AB345D5B01Q35232833-CCBA5C3A-E712-431B-8A14-286E292A7BE2Q36109219-557671C2-5382-4BAC-90BE-7E3770752318Q36475957-482CC4F7-48CF-4A2D-A560-73E1D6123240Q37365068-5774E36B-4770-458B-BA8F-50B8CD01FA42Q40128250-6E53097D-C711-40A2-9E38-36DF8ACF577FQ40225440-EC2C58DE-B859-4CAA-8E8B-2825B0248FEBQ40332290-491B1949-08FE-4807-A5D0-FB782C186EF8Q43085287-A8175E86-8698-4353-B7C9-CD498F98F4ADQ52691329-CF255878-A0DB-48FE-BE60-EA5812C01D9DQ54960967-566BEF56-346A-4F4F-83F5-DC909AA8325FQ55459013-45046A4E-019A-493D-BB94-143DDA5DE91CQ55468883-8F57F379-0572-4CBC-A48B-688B598F92E6
P2860
A novel cytomegalovirus-induced regulatory-type T-cell subset increases in size during older life and links virus-specific immunity to vascular pathology.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
A novel cytomegalovirus-induce ...... mmunity to vascular pathology.
@en
A novel cytomegalovirus-induce ...... mmunity to vascular pathology.
@nl
type
label
A novel cytomegalovirus-induce ...... mmunity to vascular pathology.
@en
A novel cytomegalovirus-induce ...... mmunity to vascular pathology.
@nl
prefLabel
A novel cytomegalovirus-induce ...... mmunity to vascular pathology.
@en
A novel cytomegalovirus-induce ...... mmunity to vascular pathology.
@nl
P2093
P2860
P356
P1476
A novel cytomegalovirus-induce ...... mmunity to vascular pathology.
@en
P2093
David Thomas
Elizabeth Cheek
Helen Smith
Martha Bajwa
Nabila Seddiki
Serena Vita
P2860
P304
P356
10.1093/INFDIS/JIT576
P407
P577
2013-11-07T00:00:00Z